OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
000553$6.8959

ADAMA Ltd

Agricultural ChemicalsVerified

ADAMA operates with a market capitalization of CNY 15.0 billion and a price-to-book ratio of 0.85, indicating a discount to its book value. The company's liquidity position is characterized by a current ratio of 1.14, suggesting limited short-term liquidity cushion. Free cash flow is negative at CNY -1.08 billion, and capital expenditures of CNY -1.21 billion reflect ongoing investment in operations. The debt-to-equity ratio of 1.01 indicates a balanced capital structure, but the negative net cash position after subtracting total debt raises liquidity concerns. Profitability metrics show a challenging operating environment for ADAMA. The company reported a net loss of CNY -1.05 billion and an operating loss of CNY -897 million, with a return on equity of -5.95% and a return on assets of -2.16%. These figures fall below the typical performance of the Agricultural Chemicals industry, which is characterized by high gross margins and stable operating returns. Geographically, ADAMA's revenue is concentrated in China, with no disclosed international segments. The company's exposure to a single market increases its vulnerability to domestic regulatory changes and economic fluctuations. No material revenue diversification is evident in the financial snapshot. The company's growth trajectory is mixed. Revenue for the latest period was CNY 28.94 billion, but the operating loss and negative net income suggest a contraction in profitability. Analysts have assigned a mean price target of CNY 7.92, slightly above the current market price of CNY 6.89, indicating a modest upside potential. However, the absence of a clear growth driver and the negative operating performance raise questions about the sustainability of future revenue expansion. Risk factors for ADAMA include liquidity constraints and the potential for further operating losses. The company's negative free cash flow and high capital expenditures suggest ongoing financial strain. While dilution risk is currently assessed as low, the negative net cash position and the need for continued investment could lead to future equity issuance. No recent dilutive events are disclosed, but the risk remains if operating performance does not improve. Recent events include the publication of the latest financial results, which show a significant operating loss and a net loss. No recent filings or transcripts have been disclosed that provide additional insight into the company's strategic direction or operational challenges. The lack of detailed guidance from management increases uncertainty for investors.

30-day price · 000553-0.04 (-0.6%)
Low$6.02High$7.63Close$6.42As of22 May, 00:00 UTC
Profile
CompanyADAMA Ltd
Ticker000553.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. ADAMA Ltd is a Chinese-based agricultural chemicals company that produces and distributes crop protection products, including herbicides, insecticides, and fungicides, primarily for the global agrochemical market.

Classification. ADAMA is classified under the Basic Materials economic sector, Chemicals business sector, and Agricultural Chemicals industry, with a confidence level of 0.92 based on verified market data.

ADAMA operates with a market capitalization of CNY 15.0 billion and a price-to-book ratio of 0.85, indicating a discount to its book value. The company's liquidity position is characterized by a current ratio of 1.14, suggesting limited short-term liquidity cushion. Free cash flow is negative at CNY -1.08 billion, and capital expenditures of CNY -1.21 billion reflect ongoing investment in operations. The debt-to-equity ratio of 1.01 indicates a balanced capital structure, but the negative net cash position after subtracting total debt raises liquidity concerns. Profitability metrics show a challenging operating environment for ADAMA. The company reported a net loss of CNY -1.05 billion and an operating loss of CNY -897 million, with a return on equity of -5.95% and a return on assets of -2.16%. These figures fall below the typical performance of the Agricultural Chemicals industry, which is characterized by high gross margins and stable operating returns. Geographically, ADAMA's revenue is concentrated in China, with no disclosed international segments. The company's exposure to a single market increases its vulnerability to domestic regulatory changes and economic fluctuations. No material revenue diversification is evident in the financial snapshot. The company's growth trajectory is mixed. Revenue for the latest period was CNY 28.94 billion, but the operating loss and negative net income suggest a contraction in profitability. Analysts have assigned a mean price target of CNY 7.92, slightly above the current market price of CNY 6.89, indicating a modest upside potential. However, the absence of a clear growth driver and the negative operating performance raise questions about the sustainability of future revenue expansion. Risk factors for ADAMA include liquidity constraints and the potential for further operating losses. The company's negative free cash flow and high capital expenditures suggest ongoing financial strain. While dilution risk is currently assessed as low, the negative net cash position and the need for continued investment could lead to future equity issuance. No recent dilutive events are disclosed, but the risk remains if operating performance does not improve. Recent events include the publication of the latest financial results, which show a significant operating loss and a net loss. No recent filings or transcripts have been disclosed that provide additional insight into the company's strategic direction or operational challenges. The lack of detailed guidance from management increases uncertainty for investors.
Key takeaways
  • ADAMA is trading at a discount to book value with a price-to-book ratio of 0.85.
  • The company reported a net loss of CNY -1.05 billion and an operating loss of CNY -897 million.
  • Free cash flow is negative at CNY -1.08 billion, and capital expenditures are CNY -1.21 billion.
  • Analysts have assigned a mean price target of CNY 7.92, slightly above the current market price.
  • The company's revenue is concentrated in China, increasing its exposure to domestic economic and regulatory risks.
  • Liquidity risk is medium, with a current ratio of 1.14 and a negative net cash position after subtracting total debt.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$28.94B
Gross profit$7.46B
Operating income-$897.4M
Net income-$1.05B
R&D
SG&A
D&A
SBC
Operating cash flow$4.05B
CapEx-$1.21B
Free cash flow-$1.08B
Total assets$48.46B
Total liabilities$30.89B
Total equity$17.58B
Cash & equivalents
Long-term debt$17.82B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$28.94B-$897.4M-$1.05B-$1.08B
FY-1$29.49B-$2.18B-$2.90B-$3.22B
FY-2$32.78B-$1.46B-$1.61B-$3.11B
FY-3$37.38B$730.2M$609.4M-$813.8M
FY-4$31.04B$516.0M$157.4M-$1.23B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$48.46B$17.58B
FY-1$50.06B$18.99B
FY-2$55.41B$21.92B
FY-3$57.98B$23.12B
FY-4$50.24B$21.08B
PeriodOCFCapExFCFSBC
FY0$4.05B-$1.21B-$1.08B
FY-1$3.76B-$1.42B-$3.22B
FY-2$2.62B-$2.37B-$3.11B
FY-3$940.7M-$2.67B-$813.8M
FY-4$4.56B-$2.59B-$1.23B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$7.21B$419.6M$569.2M
FQ-1$7.27B-$460.7M-$622.9M
FQ-2$6.65B-$304.4M-$342.5M
FQ-3$7.85B-$256.6M-$231.5M
FQ-4$7.17B$124.4M$151.1M
FQ-5$7.96B-$689.5M-$1.07B
FQ-6$6.61B-$890.3M-$943.2M
FQ-7$7.40B-$422.6M-$667.3M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$49.10B$17.92B$3.24B
FQ-1$48.46B$17.58B
FQ-2$49.93B$18.45B$3.73B
FQ-3$50.70B$18.91B
FQ-4$51.03B$19.13B$3.72B
FQ-5$50.06B$18.99B
FQ-6$51.52B$19.78B$4.18B
FQ-7$52.85B$20.98B
PeriodOCFCapExFCFSBC
FQ0-$983.2M-$270.7M
FQ-1$4.05B-$1.21B
FQ-2$2.37B-$865.7M
FQ-3$1.74B-$589.9M
FQ-4-$206.9M-$317.2M
FQ-5$3.76B-$1.42B
FQ-6$2.86B-$1.07B
FQ-7$1.73B-$800.5M
Valuation
Market price$6.89
Market cap$15.00B
Enterprise value$32.82B
P/E
Reported non-GAAP P/E
EV/Revenue1.1
EV/Op income
EV/OCF8.1
P/B0.8
P/Tangible book0.8
Tangible book$17.58B
Net cash-$17.82B
Current ratio1.1
Debt/Equity1.0
ROA-2.2%
ROE-5.9%
Cash conversion-3.9%
CapEx/Revenue-4.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric000553Activity
Op margin-3.1%0.4% medp25 -8.0% · p75 16.0%below median
Net margin-3.6%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin25.8%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-4.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity101.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean price target7.92 CNY
Median price target7.92 CNY
High price target7.92 CNY
Low price target7.92 CNY
Mean recommendation1.50 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.22 CNY
Last actual EPS-0.45 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-17 02:49 UTCJob: c6553a80